{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T11:48:29Z","timestamp":1774093709465,"version":"3.50.1"},"publisher-location":"Berlin, Heidelberg","reference-count":27,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783662578797","type":"print"},{"value":"9783662578803","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/8904_2017_57","type":"book-chapter","created":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T05:54:43Z","timestamp":1507182883000},"page":"55-62","source":"Crossref","is-referenced-by-count":10,"title":["Novel Missense LCAT Gene Mutation Associated with an Atypical Phenotype of Familial LCAT Deficiency in Two Portuguese Brothers"],"prefix":"10.1007","author":[{"given":"I.","family":"Castro-Ferreira","sequence":"first","affiliation":[]},{"given":"Rute","family":"Carmo","sequence":"additional","affiliation":[]},{"given":"S\u00e9rgio Estrela","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Ot\u00edlia","family":"Corr\u00eaa","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Sampaio","sequence":"additional","affiliation":[]},{"given":"Rodrigues-Pereira","family":"Pedro","sequence":"additional","affiliation":[]},{"given":"Augusta","family":"Pra\u00e7a","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Paulo","family":"Oliveira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,10,6]]},"reference":[{"key":"57_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5414\/CNP69213","volume":"69","author":"P Aranda","year":"2008","unstructured":"Aranda P, Valdivielso P, Pisciotta L et al (2008) Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs). Clin Nephrol 69:213\u2013218","journal-title":"Clin Nephrol"},{"key":"57_CR2","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1161\/01.ATV.0000175751.30616.13","volume":"25","author":"L Calabresi","year":"2005","unstructured":"Calabresi L, Pisciotta L, Costantin A et al (2005) The molecular basis of lecithin-cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol 25:1972\u20131978","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"57_CR3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1161\/CIRCULATIONAHA.108.848143","volume":"120","author":"L Calabresi","year":"2009","unstructured":"Calabresi L, Baldassarre D, Castelnuovo S et al (2009) Functional lecithin-cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation 120:628\u2013635","journal-title":"Circulation"},{"key":"57_CR4","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1093\/ndt\/gfm311","volume":"22","author":"V Charlton-Menys","year":"2007","unstructured":"Charlton-Menys V, Pisciotta L, Durrington PN et al (2007) Molecular characterization of two patients with severe LCAT deficiency. Nephrol Dial Transplant 22:2379\u20132382","journal-title":"Nephrol Dial Transplant"},{"key":"57_CR5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/clinchem\/38.5.776","volume":"38","author":"M Buyzere De","year":"1992","unstructured":"De Buyzere M, Delanghe J, Labeur C et al (1992) Acquired hypolipoproteinemia. Clin Chem 38:776\u2013781","journal-title":"Clin Chem"},{"key":"57_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10157-013-0895-4","volume":"18","author":"S Hirashio","year":"2014","unstructured":"Hirashio S, Ueno T, Naito T, Masaki T (2014) Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency. Clin Exp Nephrol 18:189\u2013193","journal-title":"Clin Exp Nephrol"},{"key":"57_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ki.2009.235","volume":"76","author":"R Kettritz","year":"2009","unstructured":"Kettritz R, Elitok S, Koepke ML, Kuchenbecker J, Schneider W, Luft FC (2009) The case: the eyes have it! Kidney Int 76:465\u2013466","journal-title":"Kidney Int"},{"key":"57_CR8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-2275(20)37433-2","volume":"38","author":"JA Kuivenhoven","year":"1997","unstructured":"Kuivenhoven JA, Pritchard H, Hill J et al (1997) The molecular pathology of lecithin-cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res 38:191\u2013205","journal-title":"J Lipid Res"},{"key":"57_CR9","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1194\/jlr.R024513","volume":"53","author":"S Kunnen","year":"2012","unstructured":"Kunnen S, Van Eck M (2012) Lecithin-cholesterol acyltransferase: old friend or foe in atherosclerosis? J Lipid Res 53:1783\u20131799","journal-title":"J Lipid Res"},{"key":"57_CR10","doi-asserted-by":"publisher","first-page":"15090","DOI":"10.1074\/jbc.M008466200","volume":"276","author":"G Lambert","year":"2001","unstructured":"Lambert G, Sakai N, Vaisman BL et al (2001) Analysis of glomerulosclerosis and atherosclerosis in lecithin-cholesterol acyltransferase deficient mice. J Biol Chem 276:15090\u201315098","journal-title":"J Biol Chem"},{"issue":"1","key":"57_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/nep.12554","volume":"21","author":"H Liew","year":"2016","unstructured":"Liew H, Simpson I, Kanellis J, Mulley WR (2016) Recurrent glomerulopathy in a renal allograft due to lecithin-cholesterol acyltransferase deficiency. Nephrology (Carlton) 21(1):73\u201374","journal-title":"Nephrology (Carlton)"},{"key":"57_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1046\/j.1523-1755.2001.060002520.x","volume":"60","author":"EG Lynn","year":"2001","unstructured":"Lynn EG, Siow YL, Frohlich J, Cheung GT, O K (2001) Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-kappa B. Kidney Int 60:520\u2013532","journal-title":"Kidney Int"},{"key":"57_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s10157-011-0409-1","volume":"15","author":"P Miarka","year":"2011","unstructured":"Miarka P, Idzior-Walu\u0153 B, Ku\u0178niewski M, Walu\u0153-Miarka M, Klupa T, Su\u0142owicz W (2011) Corticosteroid treatment of kidney disease in a patient with familial lecithin-cholesterol acyltransferase deficiency. Clin Exp Nephrol 15:424\u2013429","journal-title":"Clin Exp Nephrol"},{"key":"57_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000180835","volume":"18","author":"E Myhre","year":"1977","unstructured":"Myhre E, Gjone E, Flatmark A, Hovig T (1977) Renal failure in familial lecithin-cholesterol acyltransferase deficiency. Nephron 18:239\u2013248","journal-title":"Nephron"},{"key":"57_CR15","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1161\/01.ATV.0000217910.90210.99","volume":"26","author":"M Nishiwaki","year":"2006","unstructured":"Nishiwaki M, Ikewaki K, Bader G et al (2006) Human lecithin-cholesterol acyltransferase deficiency: in vivo kinetics of low-density lipoprotein and lipoprotein-X. Arterioscler Thromb Vasc Biol 26:1370\u20131375","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"57_CR16","doi-asserted-by":"publisher","first-page":"e0150083","DOI":"10.1371\/journal.pone.0150083","volume":"11","author":"A Ossoli","year":"2016","unstructured":"Ossoli A, Neufeld EB, Thacker SG et al (2016) Lipoprotein X causes renal disease in LCAT deficiency. PLoS One 11(2):e0150083","journal-title":"PLoS One"},{"key":"57_CR17","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/ICO.0b013e31819839ae","volume":"29","author":"P-M Palmiero","year":"2009","unstructured":"Palmiero P-M, Sbeity Z, Liebmann J, Ritch R (2009) In vivo imaging of the cornea in a patient with lecithin-cholesterol acyltransferase deficiency. Cornea 29:1061\u20131064","journal-title":"Cornea"},{"key":"57_CR18","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1093\/ndt\/12.11.2430","volume":"12","author":"V Panescu","year":"1997","unstructured":"Panescu V, Grignon Y, Hestin D et al (1997) Recurrence of lecithin-cholesterol acyltransferase deficiency after kidney transplantation. Nephrol Dial Transplant 12:2430\u20132432","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"57_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1124\/jpet.110.169540","volume":"335","author":"X Rousset","year":"2010","unstructured":"Rousset X, Vaisman B, Auerbach B et al (2010) Effect of recombinant human lecithin-cholesterol acyltransferase infusion on lipoprotein metabolism in mice. J Pharmacol Exp Ther 335(1):140\u2013148","journal-title":"J Pharmacol Exp Ther"},{"key":"57_CR20","first-page":"2817","volume-title":"The metabolic and molecular bases of inherited disease","author":"S Santamarina-Fojo","year":"2001","unstructured":"Santamarina-Fojo S, Hoeg J, Assmann G, Brewer HBJ (2001) Lecithin-cholesterol acyltransferase deficiency and fish eye disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2817\u20132833"},{"issue":"2","key":"57_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jacl.2015.12.007","volume":"10","author":"RD Shamburek","year":"2016","unstructured":"Shamburek RD, Bakker-Arkema R, Auerbach BJ et al (2016a) Familial lecithin-cholesterol acyltransferase deficiency: first-in-human treatment with enzyme replacement. J Clin Lipidol 10(2):356\u2013367","journal-title":"J Clin Lipidol"},{"issue":"1","key":"57_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1161\/CIRCRESAHA.115.306223","volume":"118","author":"RD Shamburek","year":"2016","unstructured":"Shamburek RD, Bakker-Arkema R, Shamburek AM et al (2016b) Safety and tolerability of ACP-501, a recombinant human lecithin-cholesterol acyltransferase, in a phase 1 single-dose escalation study. Circ Res 118(1):73\u201382","journal-title":"Circ Res"},{"key":"57_CR23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biologicals.2013.09.007","volume":"41","author":"S Simonelli","year":"2013","unstructured":"Simonelli S, Tinti C, Salvini L et al (2013) Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency. Biologicals 41:446\u2013449","journal-title":"Biologicals"},{"key":"57_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0014-5793(92)80795-I","volume":"309","author":"G Skretting","year":"1992","unstructured":"Skretting G, Blomhoff JP, Solheim J, Prydz H (1992) The genetic defect of the original Norwegian lecithin-cholesterol acyltransferase deficiency families. FEBS Lett 309:307\u2013310","journal-title":"FEBS Lett"},{"key":"57_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/01913123.2010.551578","volume":"35","author":"EH Strom","year":"2011","unstructured":"Strom EH, Sund S, Reier-Nilsen M, Dorje C, Leren TP (2011) Lecithin-cholesterol acyltransferase (LCAT) deficiency: renal lesions with early graft recurrence. Ultrastruct Pathol 35:139\u2013145","journal-title":"Ultrastruct Pathol"},{"key":"57_CR26","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1681\/ASN.2012090913","volume":"24","author":"S Takahashi","year":"2013","unstructured":"Takahashi S, Hiromura K, Tsukida M et al (2013) Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency. J Am Soc Nephrol 24:1305\u20131312","journal-title":"J Am Soc Nephrol"},{"key":"57_CR27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.atherosclerosis.2008.11.033","volume":"205","author":"MS Yee","year":"2009","unstructured":"Yee MS, Pavitt DV, Richmond W et al (2009) Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapy. Atherosclerosis 205:528\u2013532","journal-title":"Atherosclerosis"}],"container-title":["JIMD Reports","JIMD Reports, Volume 40"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/8904_2017_57","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T23:55:35Z","timestamp":1659570935000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/8904_2017_57"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783662578797","9783662578803"],"references-count":27,"URL":"https:\/\/doi.org\/10.1007\/8904_2017_57","relation":{},"ISSN":["2192-8304","2192-8312"],"issn-type":[{"value":"2192-8304","type":"print"},{"value":"2192-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}